Crossmark

Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era

Crossref DOI link: https://doi.org/10.1007/s11060-024-04749-5

Published Online: 2024-07-01

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cole, Kyril L.

Earl, Emma R.

Findlay, Matthew C.

Sherrod, Brandon A.

Tenhoeve, Samuel A.

Kunzman, Jessica

Cannon, Donald M.

Akerley, Wallace

Burt, Lindsay

Seifert, Seth B.

Goldman, Matthew

Jensen, Randy L. https://orcid.org/0000-0002-2824-4221
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-01
More Information

Article History

Received: 11 April 2024

Accepted: 13 June 2024

First Online: 1 July 2024

Declarations

:

: This study was a retrospective time-dependent analysis and was approved by the University of Utah institutional review board.

: The institutional review board approved this study with a waiver of informed consent to participate.

: There is no identifying information included in this paper.

: Randy Jensen is a consultant for Medtronic. The remaining authors have no relevant financial or institutional interests to disclose.

Document is current

Any future updates will be listed below